CIRM Funded Clinical Trials

Personalized antisense oligonucleotide therapy for rare pediatric genetic disease: SCN2A

Disease Area:
Neurological Disorders, Other
CIRM Grant:
CLIN2-15085 (Active)
Award Value:
Trial Sponsor:
University of California, San Diego
Trial Stage:
Phase 1/2
Trial Status:
Targeted Enrollment:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website